Global Metabolic Disease Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4941195
- 102 Pages
- March 2022
- Pharmaceuticals
The United States Metabolic Disease Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Metabolic Disease Drugs market, reaching US$ million by the year 2028. As for the Europe Metabolic Disease Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Metabolic Disease Drugs players cover Merck, Novartis, Takeda Pharmaceutical, and Astra Zeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metabolic Disease Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Glycogen Metabolism Disease Drug
Lipid Metabolism Disease Drug
Amino Acid Metabolism Drug
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacy
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Beohrigher Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science
Metsubishi Tanabe Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metabolic Disease Drugs Market Size 2017-2028
2.1.2 Metabolic Disease Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Metabolic Disease Drugs Segment by Type
2.2.1 Glycogen Metabolism Disease Drug
2.2.2 Lipid Metabolism Disease Drug
2.2.3 Amino Acid Metabolism Drug
2.2.4 Other
2.3 Metabolic Disease Drugs Market Size by Type
2.3.1 Metabolic Disease Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Metabolic Disease Drugs Market Size Market Share by Type (2017-2022)
2.4 Metabolic Disease Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Metabolic Disease Drugs Market Size by Application
2.5.1 Metabolic Disease Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Metabolic Disease Drugs Market Size Market Share by Application (2017-2022)
3 Metabolic Disease Drugs Market Size by Player
3.1 Metabolic Disease Drugs Market Size Market Share by Players
3.1.1 Global Metabolic Disease Drugs Revenue by Players (2020-2022)
3.1.2 Global Metabolic Disease Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Metabolic Disease Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Metabolic Disease Drugs by Regions
4.1 Metabolic Disease Drugs Market Size by Regions (2017-2022)
4.2 Americas Metabolic Disease Drugs Market Size Growth (2017-2022)
4.3 APAC Metabolic Disease Drugs Market Size Growth (2017-2022)
4.4 Europe Metabolic Disease Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Metabolic Disease Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Metabolic Disease Drugs Market Size by Country (2017-2022)
5.2 Americas Metabolic Disease Drugs Market Size by Type (2017-2022)
5.3 Americas Metabolic Disease Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metabolic Disease Drugs Market Size by Region (2017-2022)
6.2 APAC Metabolic Disease Drugs Market Size by Type (2017-2022)
6.3 APAC Metabolic Disease Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Metabolic Disease Drugs by Country (2017-2022)
7.2 Europe Metabolic Disease Drugs Market Size by Type (2017-2022)
7.3 Europe Metabolic Disease Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Metabolic Disease Drugs by Region (2017-2022)
8.2 Middle East & Africa Metabolic Disease Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Metabolic Disease Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Metabolic Disease Drugs Market Forecast
10.1 Global Metabolic Disease Drugs Forecast by Regions (2023-2028)
10.1.1 Global Metabolic Disease Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Metabolic Disease Drugs Forecast
10.1.3 APAC Metabolic Disease Drugs Forecast
10.1.4 Europe Metabolic Disease Drugs Forecast
10.1.5 Middle East & Africa Metabolic Disease Drugs Forecast
10.2 Americas Metabolic Disease Drugs Forecast by Country (2023-2028)
10.2.1 United States Metabolic Disease Drugs Market Forecast
10.2.2 Canada Metabolic Disease Drugs Market Forecast
10.2.3 Mexico Metabolic Disease Drugs Market Forecast
10.2.4 Brazil Metabolic Disease Drugs Market Forecast
10.3 APAC Metabolic Disease Drugs Forecast by Region (2023-2028)
10.3.1 China Metabolic Disease Drugs Market Forecast
10.3.2 Japan Metabolic Disease Drugs Market Forecast
10.3.3 Korea Metabolic Disease Drugs Market Forecast
10.3.4 Southeast Asia Metabolic Disease Drugs Market Forecast
10.3.5 India Metabolic Disease Drugs Market Forecast
10.3.6 Australia Metabolic Disease Drugs Market Forecast
10.4 Europe Metabolic Disease Drugs Forecast by Country (2023-2028)
10.4.1 Germany Metabolic Disease Drugs Market Forecast
10.4.2 France Metabolic Disease Drugs Market Forecast
10.4.3 UK Metabolic Disease Drugs Market Forecast
10.4.4 Italy Metabolic Disease Drugs Market Forecast
10.4.5 Russia Metabolic Disease Drugs Market Forecast
10.5 Middle East & Africa Metabolic Disease Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Metabolic Disease Drugs Market Forecast
10.5.2 South Africa Metabolic Disease Drugs Market Forecast
10.5.3 Israel Metabolic Disease Drugs Market Forecast
10.5.4 Turkey Metabolic Disease Drugs Market Forecast
10.5.5 GCC Countries Metabolic Disease Drugs Market Forecast
10.6 Global Metabolic Disease Drugs Forecast by Type (2023-2028)
10.7 Global Metabolic Disease Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Metabolic Disease Drugs Product Offered
11.1.3 Merck Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Metabolic Disease Drugs Product Offered
11.2.3 Novartis Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Information
11.3.2 Takeda Pharmaceutical Metabolic Disease Drugs Product Offered
11.3.3 Takeda Pharmaceutical Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Takeda Pharmaceutical Main Business Overview
11.3.5 Takeda Pharmaceutical Latest Developments
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Information
11.4.2 Astra Zeneca Metabolic Disease Drugs Product Offered
11.4.3 Astra Zeneca Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Astra Zeneca Main Business Overview
11.4.5 Astra Zeneca Latest Developments
11.5 Beohrigher Ingelheim
11.5.1 Beohrigher Ingelheim Company Information
11.5.2 Beohrigher Ingelheim Metabolic Disease Drugs Product Offered
11.5.3 Beohrigher Ingelheim Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Beohrigher Ingelheim Main Business Overview
11.5.5 Beohrigher Ingelheim Latest Developments
11.6 KOWA
11.6.1 KOWA Company Information
11.6.2 KOWA Metabolic Disease Drugs Product Offered
11.6.3 KOWA Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 KOWA Main Business Overview
11.6.5 KOWA Latest Developments
11.7 Kythera
11.7.1 Kythera Company Information
11.7.2 Kythera Metabolic Disease Drugs Product Offered
11.7.3 Kythera Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Kythera Main Business Overview
11.7.5 Kythera Latest Developments
11.8 Fuji yakuhin
11.8.1 Fuji yakuhin Company Information
11.8.2 Fuji yakuhin Metabolic Disease Drugs Product Offered
11.8.3 Fuji yakuhin Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Fuji yakuhin Main Business Overview
11.8.5 Fuji yakuhin Latest Developments
11.9 LG Life Science
11.9.1 LG Life Science Company Information
11.9.2 LG Life Science Metabolic Disease Drugs Product Offered
11.9.3 LG Life Science Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 LG Life Science Main Business Overview
11.9.5 LG Life Science Latest Developments
11.10 Metsubishi Tanabe Pharma
11.10.1 Metsubishi Tanabe Pharma Company Information
11.10.2 Metsubishi Tanabe Pharma Metabolic Disease Drugs Product Offered
11.10.3 Metsubishi Tanabe Pharma Metabolic Disease Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Metsubishi Tanabe Pharma Main Business Overview
11.10.5 Metsubishi Tanabe Pharma Latest Developments
12 Research Findings and Conclusion
Table 1. Metabolic Disease Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Glycogen Metabolism Disease Drug
Table 3. Major Players of Lipid Metabolism Disease Drug
Table 4. Major Players of Amino Acid Metabolism Drug
Table 5. Major Players of Other
Table 6. Metabolic Disease Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Metabolic Disease Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Metabolic Disease Drugs Market Size Market Share by Type (2017-2022)
Table 9. Metabolic Disease Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Metabolic Disease Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Metabolic Disease Drugs Market Size Market Share by Application (2017-2022)
Table 12. Global Metabolic Disease Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Metabolic Disease Drugs Revenue Market Share by Player (2020-2022)
Table 14. Metabolic Disease Drugs Key Players Head office and Products Offered
Table 15. Metabolic Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Metabolic Disease Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Metabolic Disease Drugs Market Size Market Share by Regions (2017-2022)
Table 20. Americas Metabolic Disease Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Metabolic Disease Drugs Market Size Market Share by Country (2017-2022)
Table 22. Americas Metabolic Disease Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Metabolic Disease Drugs Market Size Market Share by Type (2017-2022)
Table 24. Americas Metabolic Disease Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Metabolic Disease Drugs Market Size Market Share by Application (2017-2022)
Table 26. APAC Metabolic Disease Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Metabolic Disease Drugs Market Size Market Share by Region (2017-2022)
Table 28. APAC Metabolic Disease Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Metabolic Disease Drugs Market Size Market Share by Type (2017-2022)
Table 30. APAC Metabolic Disease Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Metabolic Disease Drugs Market Size Market Share by Application (2017-2022)
Table 32. Europe Metabolic Disease Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Metabolic Disease Drugs Market Size Market Share by Country (2017-2022)
Table 34. Europe Metabolic Disease Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Metabolic Disease Drugs Market Size Market Share by Type (2017-2022)
Table 36. Europe Metabolic Disease Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Metabolic Disease Drugs Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Metabolic Disease Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Metabolic Disease Drugs Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Metabolic Disease Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Metabolic Disease Drugs Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Metabolic Disease Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Metabolic Disease Drugs Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Metabolic Disease Drugs
Table 45. Key Market Challenges & Risks of Metabolic Disease Drugs
Table 46. Key Industry Trends of Metabolic Disease Drugs
Table 47. Global Metabolic Disease Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Metabolic Disease Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Metabolic Disease Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Metabolic Disease Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Metabolic Disease Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Metabolic Disease Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 53. Merck Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 54. Merck Metabolic Disease Drugs Product Offered
Table 55. Merck Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Merck Main Business
Table 57. Merck Latest Developments
Table 58. Novartis Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 59. Novartis Metabolic Disease Drugs Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Novartis Latest Developments
Table 63. Takeda Pharmaceutical Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 64. Takeda Pharmaceutical Metabolic Disease Drugs Product Offered
Table 65. Takeda Pharmaceutical Main Business
Table 66. Takeda Pharmaceutical Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Takeda Pharmaceutical Latest Developments
Table 68. Astra Zeneca Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 69. Astra Zeneca Metabolic Disease Drugs Product Offered
Table 70. Astra Zeneca Main Business
Table 71. Astra Zeneca Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Astra Zeneca Latest Developments
Table 73. Beohrigher Ingelheim Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 74. Beohrigher Ingelheim Metabolic Disease Drugs Product Offered
Table 75. Beohrigher Ingelheim Main Business
Table 76. Beohrigher Ingelheim Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Beohrigher Ingelheim Latest Developments
Table 78. KOWA Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 79. KOWA Metabolic Disease Drugs Product Offered
Table 80. KOWA Main Business
Table 81. KOWA Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. KOWA Latest Developments
Table 83. Kythera Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 84. Kythera Metabolic Disease Drugs Product Offered
Table 85. Kythera Main Business
Table 86. Kythera Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Kythera Latest Developments
Table 88. Fuji yakuhin Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 89. Fuji yakuhin Metabolic Disease Drugs Product Offered
Table 90. Fuji yakuhin Main Business
Table 91. Fuji yakuhin Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Fuji yakuhin Latest Developments
Table 93. LG Life Science Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 94. LG Life Science Metabolic Disease Drugs Product Offered
Table 95. LG Life Science Main Business
Table 96. LG Life Science Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. LG Life Science Latest Developments
Table 98. Metsubishi Tanabe Pharma Details, Company Type, Metabolic Disease Drugs Area Served and Its Competitors
Table 99. Metsubishi Tanabe Pharma Metabolic Disease Drugs Product Offered
Table 100. Metsubishi Tanabe Pharma Main Business
Table 101. Metsubishi Tanabe Pharma Metabolic Disease Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Metsubishi Tanabe Pharma Latest Developments
List of Figures
Figure 1. Metabolic Disease Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Metabolic Disease Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Metabolic Disease Drugs Market Size Market Share by Type in 2021
Figure 7. Metabolic Disease Drugs in Hospital Pharmacy
Figure 8. Global Metabolic Disease Drugs Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Metabolic Disease Drugs in Retail Pharmacy
Figure 10. Global Metabolic Disease Drugs Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Global Metabolic Disease Drugs Market Size Market Share by Application in 2021
Figure 12. Global Metabolic Disease Drugs Revenue Market Share by Player in 2021
Figure 13. Global Metabolic Disease Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Metabolic Disease Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Metabolic Disease Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Metabolic Disease Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Metabolic Disease Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Metabolic Disease Drugs Value Market Share by Country in 2021
Figure 19. Americas Metabolic Disease Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Metabolic Disease Drugs Market Size Market Share by Application in 2021
Figure 21. United States Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Metabolic Disease Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Metabolic Disease Drugs Market Size Market Share by Application in 2021
Figure 27. China Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Metabolic Disease Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Metabolic Disease Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Metabolic Disease Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Metabolic Disease Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Metabolic Disease Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Metabolic Disease Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Metabolic Disease Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Metabolic Disease Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
